The Discounted Cash Flow (DCF) valuation of Orgenesis Inc (ORGS) is (454,036,068,574.82) USD. With the latest stock price at 2.11 USD, the upside of Orgenesis Inc based on DCF is -21518297088954.1%.
Based on the latest price of 2.11 USD and our DCF valuation, Orgenesis Inc (ORGS) is a sell. selling ORGS stocks now will result in a potential gain of 21518297088954.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.6% - 5.9% | 5.2% |
| Long-term Growth Rate | 3.0% - 4.3% | 3.7% |
| Fair Price | (2,869,926,676,010.99) - (247,453,061,196.76) | (454,036,068,574.82) |
| Upside | -136015482275502.3% - -11727633232174.0% | -21518297088954.1% |